Listed on the Main Board of the Singapore Exchange in October 2005, C & O Pharmaceutical Technology (Holdings) Limited ("C&O") is an established and integrated pharmaceutical group in the People's Republic of China ("China" or "PRC"). Our business model spans the entire value chain in the pharmaceutical industry, from research and development ("R&D"), to manufacturing, as well as marketing and distribution of C&O Branded and third party pharmaceutical products via an extensive distribution network covering over 2,000 distributors and 300,000 clinics, pharmacies and hospitals across all parts of China.
Work include: